Comparison between Libas Consumer Products Rights Issue 2022 and Suven Life Sciences Rights Issue 2022.
Rights Issue details
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Libas Consumer Products Rights Issue 2022 and Suven Life Sciences Rights Issue 2022. Libas Consumer Products Rights Issue 2022 is listed on NSE while Suven Life Sciences Rights Issue 2022 is listed on BSE, NSE.
Rights Issue Size and Price
The issue size of Libas Consumer Products Rights Issue 2022 rights issue is ₹18.52 Crores, whereas Suven Life Sciences Rights Issue 2022 rights issue size is ₹399.80 Crores.
Rights Issue Timetable
Find all the important dates related to the rights issue. The record date of Libas Consumer Products Rights Issue 2022 is Sep 16, 2022 while record date of Suven Life Sciences Rights Issue 2022 is Oct 18, 2022.
| | Libas Consumer Products Limited | Suven Life Sciences Limited |
|---|
| Record Date | Sep 16, 2022 | Oct 18, 2022 |
| Credit of Rights Entitlements | Sep 26, 2022 | Oct 28, 2022 |
| Bid/Offer Opens On | Sep 27, 2022 | Oct 31, 2022 |
| Renunciation of Rights Entitlements | Oct 03, 2022 | Nov 03, 2022 |
| Bid/Offer Closes On | Oct 07, 2022 | Nov 10, 2022 |
| Deemed Date of Allotment | Oct 18, 2022 | Nov 18, 2022 |
| Credit Date | Oct 20, 2022 | Nov 21, 2022 |
| Listing Date | Oct 25, 2022 | Nov 24, 2022 |
Financials details
Comparison of Libas Consumer Products Rights Issue 2022 and Suven Life Sciences Rights Issue 2022 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| | Libas Consumer Products Limited | Suven Life Sciences Limited |
|---|
| Financial | Libas Consumer Products Limited Financial Information (Restated)| Period Ended | Total Revenue | Profit After Tax |
|---|
| 31-Mar-21 | 35.54 | -1.63 | | 31-Mar-22 | 46.72 | 2.56 | | Amount in ₹ Crore | | Suven Life Sciences Limited Financial Information (Restated)| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|
| 31-Mar-21 | 128.42 | 21.23 | -72.15 | | 31-Mar-22 | 108.03 | 17.16 | -122 | | Amount in ₹ Crore | |
